Adipose-derived stem cells applied to ankle pathologies: a systematic review.

Q1 Medicine
MUSCULOSKELETAL SURGERY Pub Date : 2024-03-01 Epub Date: 2023-11-09 DOI:10.1007/s12306-023-00798-7
A Arceri, A Mazzotti, E Artioli, S O Zielli, F Barile, M Manzetti, G Viroli, A Ruffilli, C Faldini
{"title":"Adipose-derived stem cells applied to ankle pathologies: a systematic review.","authors":"A Arceri, A Mazzotti, E Artioli, S O Zielli, F Barile, M Manzetti, G Viroli, A Ruffilli, C Faldini","doi":"10.1007/s12306-023-00798-7","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this systematic review was to analyze the current use of adipose-derived mesenchymal stem cells (ADMSCs) and present the available evidence on their therapeutic potential in the treatment of ankle orthopedic issues, evaluating the applications and results. A literature search of PubMed, Google Scholar, EMBASE and Cochrane Library database was performed. The review was conducted following PRISMA guidelines. Risk of bias assessment was conducted through the Methodological Index for Non-Randomized Studies (MINORS) criteria. Initial search results yielded 4348 articles. A total of 8 articles were included in the review process. No clinical evidence has demonstrated the effectiveness of one isolation method over the other, but nonenzymatic mechanical method has more advantages. In all studies included significant clinical outcomes improvement were recorded in patients affected by osteochondral lesion and osteoarthritis of ankle. All studies performed a concomitant procedure. No serious complications were reported. ADMSC injection, especially through the nonenzymatic mechanical methods, looks to be simple and promising treatment for osteochondral lesions and osteoarthritis of the ankle, with no severe complications. The current scarcity of studies and their low-quality level preclude definitive conclusions presently. LEVEL OF EVIDENCE: III.</p>","PeriodicalId":18875,"journal":{"name":"MUSCULOSKELETAL SURGERY","volume":" ","pages":"1-9"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10881601/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MUSCULOSKELETAL SURGERY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12306-023-00798-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The purpose of this systematic review was to analyze the current use of adipose-derived mesenchymal stem cells (ADMSCs) and present the available evidence on their therapeutic potential in the treatment of ankle orthopedic issues, evaluating the applications and results. A literature search of PubMed, Google Scholar, EMBASE and Cochrane Library database was performed. The review was conducted following PRISMA guidelines. Risk of bias assessment was conducted through the Methodological Index for Non-Randomized Studies (MINORS) criteria. Initial search results yielded 4348 articles. A total of 8 articles were included in the review process. No clinical evidence has demonstrated the effectiveness of one isolation method over the other, but nonenzymatic mechanical method has more advantages. In all studies included significant clinical outcomes improvement were recorded in patients affected by osteochondral lesion and osteoarthritis of ankle. All studies performed a concomitant procedure. No serious complications were reported. ADMSC injection, especially through the nonenzymatic mechanical methods, looks to be simple and promising treatment for osteochondral lesions and osteoarthritis of the ankle, with no severe complications. The current scarcity of studies and their low-quality level preclude definitive conclusions presently. LEVEL OF EVIDENCE: III.

脂肪来源的干细胞应用于踝关节病变:一项系统综述。
本系统综述的目的是分析脂肪来源的间充质干细胞(ADMSC)的当前用途,并提供其在治疗踝关节骨科问题中的治疗潜力的可用证据,评估其应用和结果。对PubMed、Google Scholar、EMBASE和Cochrane图书馆数据库进行文献检索。审查是根据PRISMA指南进行的。通过非随机研究方法指数(MINORS)标准进行偏倚风险评估。最初的搜索结果产生了4348篇文章。共有8篇文章被纳入审查过程。没有临床证据表明一种分离方法比另一种有效,但非酶机械方法更有优势。在所有纳入的研究中,受骨软骨损伤和踝关节骨关节炎影响的患者的临床结果均有显著改善。所有研究都进行了伴随手术。没有严重并发症的报告。ADMSC注射,特别是通过非酶机械方法,看起来是一种简单而有前途的治疗踝关节骨软骨病变和骨关节炎的方法,没有严重并发症。目前研究的稀缺性及其低质量水平目前无法得出明确的结论。证据级别:III。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
MUSCULOSKELETAL SURGERY
MUSCULOSKELETAL SURGERY Medicine-Surgery
CiteScore
4.50
自引率
0.00%
发文量
35
期刊介绍: Musculoskeletal Surgery – Formerly La Chirurgia degli Organi di Movimento, founded in 1917 at the Istituto Ortopedico Rizzoli, is a peer-reviewed journal published three times a year. The journal provides up-to-date information to clinicians and scientists through the publication of original papers, reviews, case reports, and brief communications dealing with the pathogenesis and treatment of orthopaedic conditions.An electronic version is also available at http://www.springerlink.com.The journal is open for publication of supplements and for publishing abstracts of scientific meetings; conditions can be obtained from the Editors-in-Chief or the Publisher.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信